Prudential Financial Inc. Sells 11,499 Shares of DaVita Inc. (NYSE:DVA)

Prudential Financial Inc. trimmed its position in DaVita Inc. (NYSE:DVA - Free Report) by 28.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 29,603 shares of the company's stock after selling 11,499 shares during the quarter. Prudential Financial Inc.'s holdings in DaVita were worth $4,662,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Franklin Resources Inc. raised its stake in shares of DaVita by 134.6% during the third quarter. Franklin Resources Inc. now owns 54,901 shares of the company's stock worth $8,885,000 after buying an additional 31,502 shares during the last quarter. FMR LLC lifted its stake in DaVita by 659.9% in the third quarter. FMR LLC now owns 177,406 shares of the company's stock valued at $29,082,000 after buying an additional 154,061 shares during the period. Atom Investors LP bought a new position in DaVita during the third quarter worth about $4,094,000. Assenagon Asset Management S.A. increased its stake in shares of DaVita by 201.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company's stock valued at $11,159,000 after acquiring an additional 49,885 shares during the last quarter. Finally, Neo Ivy Capital Management acquired a new stake in shares of DaVita in the 3rd quarter valued at approximately $726,000. 90.12% of the stock is owned by institutional investors.

DaVita Stock Performance

DVA traded down $3.63 during trading hours on Friday, reaching $150.10. The company's stock had a trading volume of 414,532 shares, compared to its average volume of 808,667. The company's 50-day moving average is $156.16 and its 200-day moving average is $157.39. DaVita Inc. has a 52 week low of $125.64 and a 52 week high of $179.60. The firm has a market cap of $12.01 billion, a PE ratio of 14.05, a price-to-earnings-growth ratio of 1.07 and a beta of 1.04. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26.

Remove Ads

DaVita (NYSE:DVA - Get Free Report) last released its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating analysts' consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, equities analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. StockNews.com downgraded shares of DaVita from a "buy" rating to a "hold" rating in a research note on Wednesday. Barclays increased their price target on DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 18th. Cowen reiterated a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a report on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.